Pathogen spectrum and epidemiology of respiratory tract infections in Quzhou, Eastern China, from November 2023 to July 2024: A post‑COVID‑19 surveillance study
PLOS One · 08.06.2026 · 21 (6) · e0346441
DOI: 10.1371/journal.pone.0346441 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.06.2026. Verfasst von Rui-Jun Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Respiratory Tract Infections, COVID-19. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Background
After the relaxation of COVID‑19 containment measures, we investigated the pathogen spectrum and epidemiological characteristics of acute respiratory infections (ARIs) in Quzhou City from 2023 to 2024.
Objective
This study aimed to investigate the pathogen spectrum and epidemiological characteristics of acute respiratory infections (ARIs) in Quzhou City from 2023 to 2024, providing a scientific basis for local prevention and control strategies.
Methods
A total of 2,800 respiratory specimens were collected from November 2023 to July 2024, comprising 1,960 influenza-like illness (ILI) cases from outpatient/emergency departments and 840 severe acute respiratory infection (SARI) cases from inpatient departments. All samples were tested for 13 common respiratory pathogens using multiplex fluorescence quantitative PCR. Etiological and epidemiological analyses were performed based on detection results and case information.
Results
The overall ARI positivity rate was 59.28% (1,660/2,800), with a male-to-female ratio of 1.07:1 (1,447/1,353). The three most prevalent pathogens were influenza virus (Flu, 23.21%, 650/2,800), Streptococcus pneumoniae (SP, 13.14%, 368/2,800), and adenovirus (ADV, 8.39%, 235/2,800). Single pathogen infections accounted for 73.55% (1,221/1,660) of positive cases, while co-infections with two or more pathogens accounted for 26.45% (439/1,660), yielding an overall co-infection rate of 15.68% (439/2,800). No significant gender difference was observed in detection rates. However, significant differences were found across case types, temporal periods, age groups, and geographic regions (P < 0.01). Children aged ≤5 years exhibited the highest positivity rate (78.00%, 378/525), while adults aged ≥65 years showed the lowest (34.53%, 144/417). Among surveillance regions, Kaihua County had the highest positivity rate (72.47%), and Changshan County the lowest (40.55%).
Conclusions
Multiple respiratory pathogens and co-infections are prevalent in Quzhou City, with distinct age-specific and seasonal patterns. These findings underscore the need for continuous multi-pathogen surveillance and integrated prevention strategies for influenza and other respiratory infectious diseases in the post-pandemic era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
ORCID-Profile: Rui-Jun Yang
Förderung
- Quzhou Municipal Science and Technology Bureau
Zitieren
APA
Yang, R. J., Wang, M., Lyu, L., You, J. L., Huang, S. T., & Zhan, B. D. (2026). Pathogen spectrum and epidemiology of respiratory tract infections in Quzhou, Eastern China, from November 2023 to July 2024: A post‑COVID‑19 surveillance study. PLOS One, 21(6), e0346441. https://doi.org/10.1371/journal.pone.0346441
Vancouver
Yang RJ, Wang M, Lyu L, You JL, Huang ST, Zhan BD. Pathogen spectrum and epidemiology of respiratory tract infections in Quzhou, Eastern China, from November 2023 to July 2024: A post‑COVID‑19 surveillance study. PLOS One. 2026;21(6):e0346441. doi:10.1371/journal.pone.0346441
BibTeX
@article{Yang2026,
author = {Yang, Rui-Jun and Wang, Min and Lyu, Lei and You, Jia-Ling and Huang, Shi-Teng and Zhan, Bing-Dong},
title = {Pathogen spectrum and epidemiology of respiratory tract infections in Quzhou, Eastern China, from November 2023 to July 2024: A post‑COVID‑19 surveillance study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0346441},
doi = {10.1371/journal.pone.0346441}
}
EUVIMED